Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid Programs

IMPORTANCE: Federal and state agencies granted temporary regulatory waivers to prevent disruptions in access to medication for opioid use disorder (MOUD) during the COVID-19 pandemic, including expanding access to telehealth for MOUD. Little is known about changes in MOUD receipt and initiation amon...

Descripción completa

Detalles Bibliográficos
Autores principales: Austin, Anna E., Tang, Lu, Kim, Joo Yeon, Allen, Lindsay, Barnes, Andrew J., Chang, Chung-Chou H., Clark, Sarah, Cole, Evan S., Durrance, Christine Piette, Donohue, Julie M., Gordon, Adam J., Huskamp, Haiden A., McDuffie, Mary Joan, Mehrotra, Ateev, Mohamoud, Shamis, Talbert, Jeffery, Ahrens, Katherine A., Applegate, Mary, Hammerslag, Lindsey R., Lanier, Paul, Tossone, Krystel, Zivin, Kara, Burns, Marguerite E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276306/
https://www.ncbi.nlm.nih.gov/pubmed/37327009
http://dx.doi.org/10.1001/jamahealthforum.2023.1422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276306/
https://www.ncbi.nlm.nih.gov/pubmed/37327009
http://dx.doi.org/10.1001/jamahealthforum.2023.1422

Ejemplares similares